Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon O Ebbert

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
Expert Opinion on Emerging Drugs|March 13, 2009
Emerging drugs for the treatment of tobacco dependenceJon O Ebbert
Evidence-Based Medicine|September 14, 2013
Varenicline and combination nicotine replacement therapy are the most effective pharmacotherapies for treating tobacco useJon O Ebbert
The New England Journal of Medicine|November 27, 2004
Methylprednisolone, valacyclovir, or both for vestibular neuritisAmit Sood, Jon O Ebbert
CNS Drugs|December 6, 2011
Pharmacological interventions for the treatment of smokeless tobacco useJon O Ebbert, Karl Fagerstrom
Mayo Clinic Proceedings|August 13, 2003
Bupropion sustained release for treatment of tobacco dependenceJ Taylor Hays, Jon O Ebbert
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 16, 2008
The missing link in tobacco controlJon O Ebbert, J Taylor Hays
JAMA|June 22, 2016
Reducing Childhood Tobacco Smoke ExposureJon O Ebbert, Robert M Jacobson
Expert Opinion on Emerging Drugs|March 25, 2014
Emerging drugs for the treatment of tobacco dependence: 2014 updateMuhamad Y Elrashidi, Jon O Ebbert
Expert Opinion on Drug Safety|December 31, 2015
The safety of treatments for tobacco use disorderMelissa A Little, Jon O Ebbert
CNS Drugs|January 11, 2003
Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefitsJ Taylor Hays, Jon O Ebbert
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Expert Opinion on Emerging Drugs|March 13, 2009
Emerging drugs for the treatment of tobacco dependenceJon O Ebbert
Evidence-Based Medicine|September 14, 2013
Varenicline and combination nicotine replacement therapy are the most effective pharmacotherapies for treating tobacco useJon O Ebbert
The New England Journal of Medicine|November 27, 2004
Methylprednisolone, valacyclovir, or both for vestibular neuritisAmit Sood, Jon O Ebbert
CNS Drugs|December 6, 2011
Pharmacological interventions for the treatment of smokeless tobacco useJon O Ebbert, Karl Fagerstrom
Mayo Clinic Proceedings|August 13, 2003
Bupropion sustained release for treatment of tobacco dependenceJ Taylor Hays, Jon O Ebbert
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 16, 2008
The missing link in tobacco controlJon O Ebbert, J Taylor Hays
JAMA|June 22, 2016
Reducing Childhood Tobacco Smoke ExposureJon O Ebbert, Robert M Jacobson
Expert Opinion on Emerging Drugs|March 25, 2014
Emerging drugs for the treatment of tobacco dependence: 2014 updateMuhamad Y Elrashidi, Jon O Ebbert
Expert Opinion on Drug Safety|December 31, 2015
The safety of treatments for tobacco use disorderMelissa A Little, Jon O Ebbert
CNS Drugs|January 11, 2003
Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefitsJ Taylor Hays, Jon O Ebbert
Pageof 28